Faranak Ansari

632 total citations
8 papers, 451 citations indexed

About

Faranak Ansari is a scholar working on Applied Microbiology and Biotechnology, General Health Professions and Organizational Behavior and Human Resource Management. According to data from OpenAlex, Faranak Ansari has authored 8 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Applied Microbiology and Biotechnology, 4 papers in General Health Professions and 2 papers in Organizational Behavior and Human Resource Management. Recurrent topics in Faranak Ansari's work include Antibiotic Use and Resistance (6 papers), Patient Satisfaction in Healthcare (4 papers) and Healthcare Systems and Technology (2 papers). Faranak Ansari is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Patient Satisfaction in Healthcare (4 papers) and Healthcare Systems and Technology (2 papers). Faranak Ansari collaborates with scholars based in Iran, Belgium and United Kingdom. Faranak Ansari's co-authors include Peter Davey, Herman Goossens, Mats Erntell, Arno Müller, Matus Ferech, Vanessa Vankerckhoven, Peter Zarb and Anis Abobaker and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Pharmacology.

In The Last Decade

Faranak Ansari

7 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faranak Ansari Iran 6 325 148 134 79 68 8 451
P. Lesprit France 11 283 0.9× 110 0.7× 113 0.8× 82 1.0× 101 1.5× 21 407
Nilam Patel United States 8 230 0.7× 99 0.7× 160 1.2× 65 0.8× 78 1.1× 15 517
Loria Pollack United States 5 360 1.1× 176 1.2× 135 1.0× 82 1.0× 129 1.9× 5 586
Meghan K. Lehmann United States 3 226 0.7× 93 0.6× 142 1.1× 60 0.8× 77 1.1× 4 402
Michaela Steib–Bauert Germany 15 363 1.1× 145 1.0× 209 1.6× 140 1.8× 74 1.1× 21 523
Brice Amadéo France 12 212 0.7× 84 0.6× 113 0.8× 74 0.9× 31 0.5× 28 450
Shannon Chan United States 11 359 1.1× 126 0.9× 190 1.4× 140 1.8× 132 1.9× 19 553
C. Dumartin France 12 351 1.1× 130 0.9× 145 1.1× 90 1.1× 58 0.9× 33 493
Michael Oinonen United States 12 228 0.7× 86 0.6× 173 1.3× 135 1.7× 77 1.1× 17 521
Suresh Raj Paudel United States 5 231 0.7× 101 0.7× 172 1.3× 49 0.6× 65 1.0× 9 436

Countries citing papers authored by Faranak Ansari

Since Specialization
Citations

This map shows the geographic impact of Faranak Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faranak Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faranak Ansari more than expected).

Fields of papers citing papers by Faranak Ansari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faranak Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faranak Ansari. The network helps show where Faranak Ansari may publish in the future.

Co-authorship network of co-authors of Faranak Ansari

This figure shows the co-authorship network connecting the top 25 collaborators of Faranak Ansari. A scholar is included among the top collaborators of Faranak Ansari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faranak Ansari. Faranak Ansari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Abobaker, Anis, et al.. (2024). 8225 Amiodarone-Induced Thyrotoxicosis; Unusual Outcome for a Relatively Common Problem. Journal of the Endocrine Society. 8(Supplement_1).
2.
Zarb, Peter, Faranak Ansari, Arno Müller, et al.. (2011). Drug Utilization 75% (DU75%) in 17 European Hospitals (2000 - 2005): Results from the ESAC-2 Hospital Care Sub Project. Current Clinical Pharmacology. 6(1). 62–70. 16 indexed citations
3.
Ansari, Faranak, Mats Erntell, Herman Goossens, & Peter Davey. (2009). The European Surveillance of Antimicrobial Consumption (ESAC) Point‐Prevalence Survey of Antibacterial Use in 20 European Hospitals in 2006. Clinical Infectious Diseases. 49(10). 1496–1504. 182 indexed citations
4.
Davey, Peter, Matus Ferech, Faranak Ansari, Arno Müller, & Herman Goossens. (2008). Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. Journal of Antimicrobial Chemotherapy. 62(6). 1441–1447. 40 indexed citations
5.
Ansari, Faranak. (2003). Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. Journal of Antimicrobial Chemotherapy. 52(5). 842–848. 177 indexed citations
6.
Ansari, Faranak. (2001). Utilization review of systemic antiinfective agents in a teaching hospital in Tehran, Iran. European Journal of Clinical Pharmacology. 57(6-7). 541–546. 21 indexed citations
7.
Ansari, Faranak. (2001). Use of systemic anti-infective agents in Iran during 1997–1998. European Journal of Clinical Pharmacology. 57(6). 547–551. 14 indexed citations
8.
Ansari, Faranak. (2000). Pharmacoepidemiology in developing countries — what can ISPE do?. Pharmacoepidemiology and Drug Safety. 9(7). 611–613. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026